Regulation of ubiquitin-specific processing protease 8 suppresses neuroinflammation

Molecular and Cellular Neuroscience

Volumn 64, Issue , 2015, Pages 74-83

  Zhu, Lihong ^a   Bi, Wei ^b   Lu, Dan ^a   Zhang, Chanjuan ^a   Shu, Xiaoming ^a   Wang, Huadong ^a   Qi, Renbing ^a   Shi, Qiaoyun ^c   Lu, Daxiang ^a  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Luteolin; Microglia; Neuroinflammation; Neuroprotection; Nrdp 1; USP 8

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; LUTEOLIN; NEUREGULIN RECEPTOR DEGRADATION PROTEIN 1; NITRIC OXIDE; PROSTAGLANDIN E2; PROTEASE 8; PROTEIN; PROTEINASE; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR; UBIQUITIN; UBIQUITIN SPECIFIC PROCESSING PROTEASE 8; UNCLASSIFIED DRUG; CARRIER PROTEIN; ESCRT PROTEIN; PTGS2 PROTEIN, MOUSE; RNF41 PROTEIN, MOUSE; UBIQUITIN THIOLESTERASE; USP8 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; MACROPHAGE; MASS SPECTROMETRY; MICROGLIA; MOUSE; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; ANIMAL; CELL LINE; DRUG EFFECTS; GENETICS; GLIA; INFLAMMATION; METABOLISM;

MURINAE;

ANIMALS; CARRIER PROTEINS; CELL LINE; CYCLOOXYGENASE 2; DINOPROSTONE; ENDOPEPTIDASES; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; INFLAMMATION; LUTEOLIN; MICE; NEUROGLIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; UBIQUITIN THIOLESTERASE;

EID: 84918815165     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2014.05.004     Document Type: Article

References (37)

1. Alwan H.A., van Leeuwen J.E. UBPY-mediated epidermal growth factor receptor (EGFR) de-ubiquitination promotes EGFR degradation. J. Biol. Chem. 2007, 19:1658-1669.
2. Berlin I., Schwartz H., Nash P.D. Regulation of epidermal growth factor receptor ubiquitination and trafficking by the USP8·STAM complex. J. Biol. Chem. 2010, 285:34909-34921.
3. Bi W., Zhu L., Wang C., Liang Y., Liu J., Shi Q., Tao E. Rifampicin inhibits microglial inflammation and improves neuron survival against inflammation. Brain Res. 2011, 1395:12-20.
4. Bi W., Jing X., Zhu L., Liang Y., Liu J., Yang L., Xiao S., Xu A., Shi Q., Tao E. Inhibition of 26S protease regulatory subunit 7 (MSS1) suppresses neuroinflammation. Plos One 2012, 7:e36142. (doi: 10.1371).
5. Dirscherl K., Karlstetter M., Ebert S., Kraus D., Hlawatsch J., Walczak Y., Moehle C., Fuchshofer R., Langmann T. Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype. J. Neuroinflammation 2010, 14. 10.1186/1742-2094-7-3.
6. Eikelenboom P., van Gool W.A. Neuroinflammatory perspectives on the two faces of Alzheimer's disease. J. Neural Transm. 2004, 111:281-294.
7. Ge F., Lu X.P., Zengm H.L., He Q.Y., Xiong S., Jin L., He Q.Y. Proteomic and functional analyses reveal a dual molecular mechanism underlying arsenic-induced apoptosis in human multiple myeloma cells. J. Proteome Res. 2009, 8:3006-3019.
8. Gloria G.V., Perla K.C., Santa R.A., Slivia M.F. Luteolin inhibits lipopolysaccharide actions on human gingival fibroblasts. Eur. J. Pharmacol. 2006, 541:95-105.
9. Jang S., Kelley K.W., Johnson R.W. Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc. Natl. Acad. Sci. U. S. A. 2008, 7:7534-7539.
10. Jang S., Dilger R.N., Johnson R.W. Luteolin inhibits microglia and alters hippocampal-dependent spatial working memory in aged mice. J. Nutr. 2010, 140:1892-1898.
11. Jessie K., Pang W.W., Haji Z., Rahim A., Hashim O.H. Proteomic analysis of whole human saliva detects enhanced expression of interleukin-1 receptor antagonist, thioredoxin and lipocalin-1 in cigarette smokers compared to non-smokers. Int. J. Mol. Sci. 2010, 11:4488-4505.
12. Kao T.K., Ou Y.C., Lin S.Y., Pan H.C., Song P.J., Raung S.L., Lai C.Y., Liao S.L., Lu H.C., Chen C.J. Luteolin inhibits cytokine expression in endotoxin/cytokine-stimulated microglia. J. Nutr. Biochem. 2011, 22:612-624.
13. Kim J.S., Jobin C. The flavonoid luteolin prevents lipopolysaccharide-induced NF-κB signaling and gene expression by blocking IB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells. Immunology 2005, 115:375-387.
14. Kim S.H., Shin K.J., Kim D., Kim Y.H., Han M.S., Lee T.G. Luteolin inhibits the nuclear factor-κB transcriptional activity in Rat-1 fibroblasts. Biochem. Pharmacol. 2003, 66:955-963.
15. Kim J.S., Lee H.J., Lee M.H., Kim J., Jin C., Ryu J.H. Luteolin inhibits LPS-stimulated inducible nitric oxide synthase expression in BV2 microglia cells. Planta Med. 2006, 72:65-68.
16. 2) in NF-kappaB activation. Free Radic. Biol. 2008, 45:885-896.
17. Koning N., Bö L., Hoek R.M., Huitinga I. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions. Ann. Neurol. 2007, 62:504-514.
18. Krause D.L., Müller N. Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer's disease. Int. J. Alzheimers Dis. 2010, (pii, 732806).
19. Lei T., He Q.Y., Cai Z., Zhou Y., Wang Y.L., Si L.S., Cai Z., Chiu J.F. Proteomic analysis of chromium cytotoxicity in cultured rat lung epithelial cells. Proteomics 2008, 8:2420-2429.
20. Liu B., Hong J.S. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 2003, 304:1-7.
21. Mizuno E., Iura T., Mukai A., Yoshimori T., Kitamura N., Komada M. Regulation of epidermal growth factor receptor down-regulation by UBPY-mediated deubiquitination at endosomes. Mol. Biol. Cell 2005, 16:5163-5174.
22. Mizuno E., Kitamura N., Komada M14-3-3-dependent inhibition of the deubiquitinating activity of UBPY and its cancellation in the M phase. Exp. Cell Res. 2007, 1:3624-3634.
23. Naviglio S., Mattecucci C., Matoskova B., Nagase T., Nomura N., Di Fiore P.P., Draetta G.F. UBPY: a growth-regulated human ubiquitin isopeptidase. EMBO J. 1998, 15:3241-3250.
24. Niendorf S., Oksche A., Kisser A., Löhler J., Prinz M., Schorle H., Feller S., Lewitzky M., Horak I., Knobeloch K.P. Essential role of ubiquitin-specific protease 8 for receptor tyrosine kinase stability and endocytic trafficking in vivo. Mol. Cell. Biol. 2007, 27:5029-5039.
25. Nijman S.M., Luna-Vargas M.P., Velds A., Brummelkamp T.R., Dirac A.M., Sixma T.K., Bernards R. A genomic and functional inventory of deubiquitinating enzymes. Cell 2005, 2:773-786.
26. Park E., Kum S., Wang C., Park S.Y., Kim B.S., Schuller-Levis G. Anti-inflammatory activity of herbal medicines: inhibition of nitric oxide production and tumor necrosis factor-alpha secretion in an activated macrophage-like cell line. Am. J. Chin. Med. 2005, 33:415-424.
27. Petrova T.V., Akama K.T., VanEldik L.J. Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric oxide 12,14-synthase by 15-deoxy- prostaglandin J2. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:4668-4673.
28. Qian L., Flood P.M., Hong J.S. Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy. J. Neural Transm. 2010, 117:971-979.
29. Rezai-Zadeh K., Ehrhart J., Bai Y., Sanberg P.R., Bickford P., Tan J., Shytle R.D. Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression. J. Neuroinflammation 2008, 25(5):41.
30. Row P.E., Prior I.A., McCullough J., Clague M.J., Urbé S. The ubiquitin isopeptidase UBPY regulates endosomal ubiquitin dynamics and is essential for receptor down-regulation. J. Biol. Chem. 2006, 5(281):18.
31. Tsikas D. Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: appraisal of the Griess reaction in the l-arginine/nitric oxide area of research. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2007, 15:51-70.
32. Wang Y., Cheung Y.H., Yang Z., Chiu J.F., Che C.M. Proteomic approach to study the cytotoxicity of dioscin (saponin). Proteomics 2006, 6:2422-2432.
33. Wang C., Chen T., Zhang J., Yang M., Li N., Xu X., Cao X. The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon. Nat. Immunol. 2009, 10:744-752.
34. Wang Y., Yu C., Pan Y., Li J., Zhang Y., Ye F., Yang S., Zhang H., Li X., Liang G. A novel compound c12 inhibits inflammatory cytokine production and protects from inflammatory injury in vivo. PLoS One 2011, 6:e24377.
35. Woo M.S., Jang P.G., Park J.S., Kim W.K., Jon T.H. Selective modulation of lipopolysaccharide-stimulated cytokine expression and mitogen-activated protein kinase pathways by dibutyryl-cAMP in BV2 microglial cells. Mol. Brain Res. 2003, 113:86-96.
36. Wu X., Yen L., Irwin L., Sweeney C., Carraway K.L. Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8. Mol. Cell. Biol. 2004, 24:7748-7757.
37. Zhu L.H., Bi W., Qi R.B., Wang H.D., Lu D.X. Luteolin inhibits microglial inflammation and improves neuron survival against inflammation. Int. J. Neurosci. 2011, 121:329-336.